RESULTS

Hedge fund giant Man Group sees funds under management hit record high as alternative strategies rise

Hedge fund giant Man Group sees funds under management hit record high as alternative strategies rise

Man Group, the publicly-quoted London-headquartered global hedge fund group, has seen its funds under management hit record highs, with its hedge funds and alternative strategies posting strong performances amid 2020’s unprecedented coronavirus-fuelled turbulence, despite a fall in annual pre-tax profits for the company.

MANAGER INSIGHTS

“Excess returns”: UBP alternatives group targets Covid-hit credit with new distressed fund

“Excess returns”: UBP alternatives group targets Covid-hit credit with new distressed fund

Seizing on the assortment of opportunities arising from the ongoing coronavirus crisis, Union Bancaire Privée (UBP) has unveiled a new credit-focused strategy which taps into stressed and distressed situations within mid-market US and European corporate credit, collateralised loan obligations and segments of the European commercial real estate sector.

FUND PERFORMANCE

How data is driving quant hedge fund Aspect Capital’s global macro gains

How data is driving quant hedge fund Aspect Capital’s global macro gains

With the shape of the post-pandemic recovery still in flux, London-based quantitative hedge fund firm Aspect Capital believes its computer-driven global macro strategy is well positioned to capitalise on both short-term market dislocations and medium-term trends this year, as well as benefitting from relative value opportunities amid the varying recovery speeds.

FUND PERFORMANCE

Healthcare hedge fund Rhenman gauges “crucial” impact of Biden administration’s planned reforms

Healthcare hedge fund Rhenman gauges “crucial” impact of Biden administration’s planned reforms

The incoming US administration led by Joe Biden will be a “crucial” factor looming large over the healthcare industry this year, with planned reforms heralding potentially far-reaching implications for healthcare stocks and drug prices, Rhenman & Partners Asset Management said this week.